Literature DB >> 1395035

Changes in enzyme expression related to differentiation and regulatory factors: the acid phosphatase of osteoclasts and other macrophages.

D W Moss1.   

Abstract

Human tartrate-resistant Type 5 acid phosphatase is a unique isoenzyme encoded by a gene located on chromosome 19. It is a member of a widely-distributed and structurally highly-conserved group of iron-containing proteins. It is normally expressed in certain tissue macrophages, notably osteoclasts and alveolar macrophages, but is virtually absent from the precursor monocytes. Factors which enhance or inhibit expression of this specific isoenzyme can be studied in monocytes and osteoclasts cultured in vitro. This provides opportunities to develop the use of Type 5 acid phosphatase as a reporter of pathophysiological events and an essential, though not sufficient, role in bone resorption by osteoclasts has been established by such studies.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1395035     DOI: 10.1016/0009-8981(92)90344-p

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  4 in total

1.  Predictors of osteoclast activity in patients with sickle cell disease.

Authors:  Mehdi Nouraie; Kevin Cheng; Xiaomei Niu; Evadne Moore-King; Margaret F Fadojutimi-Akinsi; Caterina P Minniti; Craig Sable; Sohail Rana; Niti Dham; Andrew Campbell; Gregory Ensing; Gregory J Kato; Mark T Gladwin; Oswaldo L Castro; Victor R Gordeuk
Journal:  Haematologica       Date:  2011-05-05       Impact factor: 9.941

2.  Biochemical diagnosis of liver disease.

Authors:  P L Wolf
Journal:  Indian J Clin Biochem       Date:  1999-01

3.  Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease.

Authors:  C E Hollak; S van Weely; M H van Oers; J M Aerts
Journal:  J Clin Invest       Date:  1994-03       Impact factor: 14.808

4.  Association of Tartrate-Resistant Acid Phosphatase-Expressed Macrophages and Metastatic Breast Cancer Progression.

Authors:  Yu-Guang Chen; Anthony Janckila; Tsu-Yi Chao; Ren-Hua Yeh; Hong-Wei Gao; Su-Huei Lee; Jyh-Cherng Yu; Guo-Shiou Liao; Ming-Shen Dai
Journal:  Medicine (Baltimore)       Date:  2015-12       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.